A rare case of pulmonary thromboembolism with lobar pneumonia in a factor 7 deficiency patient

Hari Kiran Thalari; Meenakshi Bhattacharya; Ishank Gupta; Punam Jadhav

doi:10.18203/2320-6012.ijrms20243400

Authors

Hari Kiran Thalari Department of Medicine, Government Medical College and Hospital, Aurangabad, Maharashtra, India
Meenakshi Bhattacharya Department of Medicine, Government Medical College and Hospital, Aurangabad, Maharashtra, India
Ishank Gupta Department of Medicine, Government Medical College and Hospital, Aurangabad, Maharashtra, India
Punam Jadhav Department of Medicine, Government Medical College and Hospital, Aurangabad, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243400

Keywords:

Factor 7 deficiency, Pneumonia, Pulmonary embolism

Abstract

While thrombotic events are uncommon in individuals with Factor VII deficiency, they have been documented, particularly when other prothrombotic risk factors are present, such as recent surgical interventions, trauma, or factor replacement therapy. This case report discusses a 45-year-old male with a known history of Factor VII deficiency who initially presented with symptoms of fever and productive cough, leading to a diagnosis of lobar pneumonia based on clinical examination and chest X-ray results. However, after four days of hospitalization, the patient exhibited persistent coughing, occasional hemoptysis, and breathlessness, raising clinical suspicion of pulmonary thromboembolism (PTE), which was later confirmed via computed tomography pulmonary angiography. Treatment with anticoagulation led to significant clinical improvement. This case illustrates that despite having Factor VII deficiency, the patient developed PTE.

Metrics

Metrics Loading ...

References

Factor VII deficiency. Available at: https://rarediseases.org/rare-diseases/factor-vii. Accessed on 12 August 2024.

Li L, Wu X, Wu W. A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency. Thrombosis J. 2023;21:493-5.

Lapecorella M, Mariani G; International Registry on Congenital Factor VII Deficiency. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia. 2008;14(6):1170-5.

Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost. 2009;35(4):400-6.

Singh B, Modi V, Kaur P, Guron G, Maroules M. Unprovoked pulmonary embolism in factor vii deficiency. Acta Haematol. 2020;143(2):181-3.

Ramdass SK, Loh KP, Howard LM. Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency. Clin Case Rep. 2017;5(3):277-9.

Ruiz-Sáez A. Thrombosis in rare bleeding disorders. Hematology. 2012;1:156-8.

8)Anderson FA, Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;23(1):9–16

Heit JA. Risk factors for venous thromboembolism. Clin Chest Med. 2003;24:1–12.

10) Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367:1075–9.

Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657–63.

Cervantes J, Rojas G. Virchow's Legacy: deep vein thrombosis and pulmonary embolism. World J Surg. 2005;29(1):30–4.

Bhagat K, Moss R, Collier J, Vallance P. Endothelial “stunning” following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res. 1996;32:822–9.

Copur AS, Smith PR, Gomez V, Bergman M, Homel P. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS. 2002;16:205–9.

Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Hepatitis C virus infection and risk of venous thromboembolism: a systematic review and meta-analysis. Ann Hepatol. 2017;16:514–20.

Schimanski S, Linnemann B, Luxembourg B, Seifried E, Jilg W, Lindhoff-Last E, et al. Cytomegalovirus infection is associated with venous thromboembolism of immunocompetent adults: a case-control study. Ann Hematol. 2012;91:597–604.

Paran Y, Halutz O, Swartzon M, Schein Y, Yeshurun D, Justo D. Venous thromboembolism and cytomegalovirus infection in immunocompetent adults. Isr Med Assoc J. 2007;9:757–8.

Yildiz H, Zech F, Hainaut P. Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions. Acta Clin Belg. 2016;71:231–4.

Kiser KL, Badowski ME. Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection. Pharmacotherapy. 2010;30:1292–302.

Lozinguez O, Arnaud E, Belec L, Nicaud V, Alhenc-Gelas M, Fiessinger JN, et al. Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic disease. Thromb Haemost. 2000;83:887–91.

Koster T, Rosendaal FR, Lieuw-A-Len DD, Kroes AC, Emmerich JD, van Dissel JT. Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis. Lancet. 2000;355:1694–5.

Cohoon KP, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is infection an independent risk factor for venous thromboembolism? A population-based, case-control study. Am J Med. 2018;131:307–16.